Abstract
Primary brain tumors exhibit an increased uptake of amino acids. Nuclear medicine utilizes this property of glioma for cancer imaging using radioactive amino acids. Single photon emission tomography (SPECT) using p-[123I]iodo-L-phenylalanine (IPA) is a valid method for brain tumor imaging. This chapter discusses the experience with IPA-SPECT in patients with suspected glioma or suspected progression/ recurrence of glioma. The imaging procedure, the coregistration process with nuclear magnetic resonance imaging (MRI), and potential pitfalls of image interpretation are described in detail. The clinical relevance of the results obtained in clinical studies is also discussed. The implications of quantitative analyses of the kinetics of IPA in brain tumors are reported in the light of the potential therapeutic application of radioiodinated IPA (131I-IPA).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
REFERENCES
DeAngelis, L.M. (2001) Brain tumors. N. Engl. J. Med. 344:114–123
Hellwig, D., Ketter, R., Romeike, B.F., Sell, N., Schaefer, A., Moringlane, J.R., Kirsch, C.M., and Samnick, S. (2005) Validation of brain tumour imaging with p-[123I]iodo-L-phenylalanine and SPECT. Eur. J. Nucl. Med. Mol. Imaging 32:1041–1049
Hellwig, D., Gouverneur, E., Schaefer, A., Raedle, J., Menges, M., Kirsch, C.M., and Samnick, S. (2008a) Para-[123I]iodo-L-phenylalanine in patients with pancreatic adenocarcinoma: tumour uptake, whole-body kinetics, dosimetry. Nuklearmedizin 47:220–224
Hellwig, D., Romeike, B.F., Ketter, R., Moringlane, J.R., Kirsch, C.M., and Samnick, S. (2008b) Intra-individual comparison of p-[123I]-iodo-L-phenylalanine and L-3-[ 123I]-iodo-alpha-methyl-tyrosine for SPECT imaging of gliomas. Eur. J. Nucl. Med. Mol. Imaging 35:24–31
Lahoutte, T., Mertens, J., Caveliers, V., Franken, P.R., Everaert, H., and Bossuyt, A. (2003) Comparative biodistribution of iodinated amino acids in rats: selection of the optimal analog for oncologic imaging outside the brain. J. Nucl. Med. 44:1489–1494
Langen, K.J., and Broer, S. (2004) Molecular transport mechanisms of radiolabeled amino acids for PET and SPECT. J. Nucl. Med. 45:1435–1436
Matheja, P., Rickert, C., Weckesser, M., Palkovic, S., Lottgen, J., Riemann, B., Kopka, K., Kuwert, T., Wassmann, H., Paulus, W., and Schober, O. (2000) Sequential scintigraphic strategy for the differentiation of brain tumours. Eur. J. Nucl. Med. 27:550–558
Pauleit, D., Floeth, F., Hamacher, K., Riemenschneider, M.J., Reifenberger, G., Müller, H.W., Zilles, K., Coenen, H.H., and Langen, K.J. (2005) O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain 128:678–687
Romeike, B.F., Hellwig, D., Heimann, A., Kempski, O., Feiden, W., Kirsch, C.M., and Samnick, S. (2004) Action and efficacy of p-[131I]iodo-L-phenylalanine on primary human glioma cell cultures and rats with C6-gliomas. Anticancer Res. 24:3971–3976
Samnick, S., Richter, S., Romeike, B.F., Heimann, A., Feiden, W., Kempski, O., and Kirsch, C.M. (2000) Investigation of iodine-123-labelled amino acid derivatives for imaging cerebral gliomas: uptake in human glioma cells and evaluation in stereotactically implanted C6 glioma rats. Eur. J. Nucl. Med. 27:1543–1551
Samnick, S., Schaefer, A., Siebert, S., Richter, S., Vollmar, B., and Kirsch, C.M. (2001) Preparation and investigation of tumor affinity, uptake kinetic and transport mechanism of iodine-123-labelled amino acid derivatives in human pancreatic carcinoma and glioblastoma cells. Nucl. Med. Biol. 28:13–23
Samnick, S., Hellwig, D., Bader, J.B., Romeike, B.F., Moringlane, J.R., Feiden, W., and Kirsch, C.M. (2002) Initial evaluation of the feasibility of single photon emission tomography with p-[123I]iodo-L-phenylalanine for routine brain tumour imaging. Nucl. Med. Commun. 23:121–130
Samnick, S., Romeike, B.F., Kubuschok, B., Hellwig, D., Amon, M., Feiden, W., Menger, M.D., and Kirsch, C.M. (2004) p-[123I]iodo-L-phenylalanine for detection of pancreatic cancer: basic investigations of the uptake characteristics in primary human pancreatic tumour cells and evaluation in in vivo models of human pancreatic adenocarcinoma. Eur. J. Nucl. Med. Mol. Imaging 31:532–541
Vander Borght, T., Asenbaum, S., Bartenstein, P., Halldin, C., Kapucu, O., Van Laere, K., Varrone, A., and Tatsch, K. (2006) EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues. Eur. J. Nucl. Med. Mol. Imaging 33:1374–1380
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Netherlands
About this chapter
Cite this chapter
Hellwig, D. (2011). Brain Tumor Imaging Using p-[123I]Iodo-L-Phenylalanine and SPECT. In: Hayat, M. (eds) Methods of Cancer Diagnosis, Therapy, and Prognosis. Methods of Cancer Diagnosis, Therapy and Prognosis, vol 8. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-8665-5_18
Download citation
DOI: https://doi.org/10.1007/978-90-481-8665-5_18
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-8664-8
Online ISBN: 978-90-481-8665-5
eBook Packages: MedicineMedicine (R0)